LegisTrack
Back to all bills
S 999119th CongressIn Committee

Public Health Improvement Act

Introduced: Mar 12, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

The Public Health Improvement Act would make sweeping changes to the governance, scope, and authority of major U.S. public health agencies. Key elements include imposing a 12-year total term limit on leaders of the CDC and NIH, narrowing the content of the CDC’s strategic plan to focus on diseases (removing emphasis on noncommunicable diseases, injuries, and environmental or occupational hazards), and reshaping the CDC’s advisory committee with a new mix of appointments from the Administration, Congress, and the Comptroller General. The bill would transfer several major CDC offices to the NIH after two years, tighten the regulation of public health authorities by limiting the scope to communicable-disease control, require congressional approval for public health emergency determinations (with a 90-day renewal mechanism and a 48-hour reporting requirement), require the Secretary of Health and Human Services to issue new regulations to implement the act within 90 days, and include strong preemption of conflicting laws. In short, the bill would curb some emergency powers, restructure leadership and advisory processes, and realign certain public health functions under NIH rather than CDC.

Key Points

  • 1Term limits for top agency leaders: No individual may serve as CDC Director or NIH Director for more than a total of 12 years.
  • 2Narrowed focus of the CDC strategic plan: The plan would be limited to diseases, removing references to noncommunicable diseases/conditions, injuries, and certain environmental or occupational hazards.
  • 3New CDC advisory committee structure: The advisory committee would be reconfigured with specified appointments (3 by the Secretary of Health and Human Services, including one public health official; 2 by the Senate majority leader; 2 by the Senate minority leader; 2 by the House Speaker; 2 by the House minority leader; and 4 by the Comptroller General).
  • 4Major reorganization of offices: Beginning two years after enactment, several CDC offices would be transferred from the CDC to the NIH, including centers focusing on birth defects and development, chronic disease prevention, environmental health, health statistics, HIV/viral hepatitis/STD/TB prevention, injury prevention, and occupational safety and health, among others.
  • 5Expanded congressional oversight and regulatory changes: Public health emergency determinations would require renewal by a majority vote in both chambers, with a renewal period ending when the emergency is no longer in effect or after 90 days from a joint Congressional vote, and the Secretary must notify Congress within 48 hours of such determinations. The act also requires new regulations within 90 days to implement these changes and includes preemption over inconsistent laws.

Impact Areas

Primary group/area affected- Federal public health leadership and administration (CDC and NIH), including the career leadership pipeline and agency governance.Secondary group/area affected- Public health researchers and professionals who work in or with the transferred NIH offices (e.g., birth defects, environmental health, health statistics, and infectious disease prevention).Additional impacts- States, local health departments, and healthcare providers that interact with federal public health programs could see changes in regulatory scope, reporting structures, and emergency oversight.- Public health emergency planning and response could be more constrained or more politically navigated due to required congressional approval for renewals.- The broader strategic emphasis of the nation’s public health infrastructure could shift from a broad, preventive health focus to a more disease-centric framework, with potential implications for chronic disease and injury prevention programs.- The regulatory environment would be more tightly tethered to Congress and GAO/Comptroller General oversight, potentially affecting how quickly new public health regulations can be issued or modified.This is an introduced bill (as of its text) with no indicated enacted status. If enacted, it would represent a significant reorganization and shift in public health authority and oversight. The sponsors are Senators Schmitt and Lee, and the text specifies substantial changes to leadership limits, advisory appointments, office realignments, and emergency authorities.
Generated by gpt-5-nano on Nov 18, 2025